HypeCheck

Last verified: 17 days ago

Agarikon

Also known as: Fomitopsis officinalis, Laricifomes officinalis, quinine conk, AGARIKON.1, AGARIKON PLUS

Evidence under review. — Not yet rated

Medicinal mushroom extract studied in animal cancer models. No human clinical trials exist yet.

  • What it does

    Agarikon refers to a rare bracket fungus historically used in traditional medicine, and more recently to proprietary mushroom extract blends (AGARIKON.1, AGARIKON PLUS) containing multiple...

  • Evidence quality

    Evidence base hasn't been formally rated yet. See research below.

  • Clinical dose

    No established dose (insufficient research data)

What the Science Says

Agarikon refers to a rare bracket fungus historically used in traditional medicine, and more recently to proprietary mushroom extract blends (AGARIKON.1, AGARIKON PLUS) containing multiple medicinal mushroom species. In mouse colorectal cancer models, these extracts showed anti-tumor, immune-stimulating, and anti-angiogenic effects, including improved survival and reduced tumor volume. The research is early-stage — all findings come from cell cultures and animal studies, with no human clinical trials completed.

What It Doesn't Do

Not proven to treat or prevent cancer in humans. No human trial data exists. Don't confuse animal study results with proven human benefits. Not a replacement for conventional cancer treatment. No evidence it prevents viral infections like HIV or hepatitis in humans despite marketing claims.

Evidence-Based Benefits

Reduced tumor volume and improved survival in mice with advanced colorectal cancer.

Weak Evidence

Effective at: No established dose

Supporting studies (click to view on PubMed):

Shifted immune cell activity toward anti-tumor responses in colorectal cancer mouse models.

Weak Evidence

Effective at: No established dose

Supporting studies (click to view on PubMed):

Absorption & Bioavailability

Unknown — no human pharmacokinetic or absorption data available from the provided studies

Red Flags to Watch For

  • Zero human clinical trials — all efficacy data comes from mice and cell cultures
  • Products are marketed for cancer and serious viral infections (HIV, hepatitis) without human trial evidence
  • Proprietary blends make it impossible to know which mushroom species or doses you are actually getting
  • Over 1,000 supplement products registered despite extremely limited scientific evidence
  • Registration as a dietary supplement in Croatia (2010) does not equal clinical proof of efficacy

Products Containing Agarikon

See how Agarikon is used in these analyzed products:

Frequently Asked Questions

What does Agarikon do?

Medicinal mushroom extract studied in animal cancer models. No human clinical trials exist yet.

What is the effective dose of Agarikon?

No established dose (insufficient research data)

Is Agarikon safe?

Zero human clinical trials — all efficacy data comes from mice and cell cultures

What doesn't Agarikon do?

Not proven to treat or prevent cancer in humans.

Research Sources

  • PubMed
  • NIH DSLD

This information is for educational purposes only and is not medical advice. Always consult a healthcare professional before starting any supplement regimen. Last updated: 2026-05-25